Hot flashes.
Mr. J is a 68-year-old African American man with a history of advanced prostate cancer. He was diagnosed nine months prior with adenocarcinoma of the prostate, with a Gleason score of 9 and tumor, node, metastasis staging of T3 NO M1. His prostate-specific antigen (PSA) was 483 ng/ml at the time of diagnosis. He immediately began treatment with total androgen blockade after the staging workup was completed.
Engstrom
Christine
C
Veterans Affairs Maryland Health Care System, Bethesda, USA. cengstrom@usuhs.mil
D000230:Adenocarcinoma / Q000175:diagnosis / Q000188:drug therapy*; D000368:Aged; D000726:Androgen Antagonists / Q000009:adverse effects*; D000813:Anilides / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D019317:Evidence-Based Medicine; D019584:Hot Flashes / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D008297:Male; D009570:Nitriles; D009730:Nursing Assessment; D010347:Patient Care Planning; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D013546:Sweating / Q000187:drug effects; D014105:Tosyl Compounds
D000726:Androgen Antagonists; D000813:Anilides; D000970:Antineoplastic Agents; D009570:Nitriles; D014105:Tosyl Compounds; C053541:bicalutamide